 |
 |
 |
 |
 |
Return-Path: <owner-cyto-sendout@flowcyt.cyto.purdue.edu>
Received: from msmail by SmtpIn.em.cdc.gov id <314E7F8A@SmtpIn.em.cdc.gov>;
Tue, 19 Mar 96 13:34:02 EST
Received: from flowcyt.cyto.purdue.edu by msmail (5.0/SMI-SVR4) id AA26309;
Tue, 19 Mar 1996 13:35:10 -0500
Received: by flowcyt.cyto.purdue.edu (950215.SGI.8.6.10/930416.SGI.AUTO) for
cyto-sendout id MAA18470; Tue, 19 Mar 1996 12:01:41 -0500
Received: from upsmot01.msn.com by flowcyt.cyto.purdue.edu via ESMTP
(950215.SGI.8.6.10/930416.SGI.AUTO) for
<cytometry@flowcyt.cyto.purdue.edu> id WAA16596; Mon, 18 Mar 1996
22:50:54
-0500
Received: from upmajb04.msn.com ([204.95.110.81]) by upsmot01.msn.com
(8.6.8.1/Configuration 4) with SMTP id TAA14808 for
<cytometry@flowcyt.cyto.purdue.edu>; Mon, 18 Mar 1996 19:40:45 -0800
Date: Tue, 19 Mar 96 03:25:24 UT
From: "Keith Bahjat" <KBahjat@msn.com>
Message-Id: <UPMAIL05.199603190327330458@msn.com>
To: Cytometry Mailing List <cytometry@flowcyt.cyto.purdue.edu>
Subject: Lymph Node Prep
content-length: 526
----------------------------------------------------------------------------
--
Can someone please tell me if there is any benefit to using density gradient
separation on cells from a lymph node (be it a biopsy or FNA) if you are
already using viability gating?
What I saw with viability gating looked pretty straight forward, and I
couldn't see why any separation media would be needed.
I would be interested in any and all experience people have had with the two
techniques.
Thanks in advance.
Keith Bahjat
South Bend Medical Foundation
South Bend, Indiana
219-234-4176 x282
E-mail: Kbahjat@MSN.com
|
|
|
|
|
|
CD-ROM Vol 3 was produced by Monica M. Shively and other staff at the
Purdue University Cytometry Laboratories and distributed free of charge
as an educational service to the cytometry community.
If you have any comments please direct them to
Dr. J. Paul Robinson, Professor & Director,
PUCL, Purdue University, West Lafayette, IN 47907.
Phone: (765)-494-0757;
FAX(765) 494-0517;
Web